Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Borderline Personality Disorder
NCT01212588Phase 2Terminated
- Sponsor
- Indiana University
- Start
- Sep 2010
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in borderline personality disorder (BPD), sponsored by Indiana University. Started Sep 2010; status: terminated.
02
Drugs
mifepristone
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT01212588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212588.